Chapter 014
Chapter 014
Chapter 014
KEY POINTS
INFECTIONS
An infection is an invasion of the body by a pathogen (any microorganism that
causes disease) and the resulting signs and symptoms that develop in response to the
invasion.
Infections can be divided into localized, disseminated, and systemic disease.
TYPES OF PATHOGENS
The most common types of pathogens are bacteria, viruses, fungi, and protozoa.
Agents cause infection in two ways: They grow inside human cells, causing
damage, or they secrete toxins that damage cells.
EMERGING INFECTIONS
An emerging infection is an infectious disease whose incidence has increased in
the past 20 years or threatens to increase in the immediate future. Examples include
Ebola, MERS, H1N1, SARS, West Nile virus, and Zika.
Emerging infectious diseases can originate from unknown sources, contact with
animal or insect vectors, changes in known diseases, or biologic warfare. Global travel,
population density, encroachment into new environments, misused antibiotics, and
bioterrorism have contributed to the increased risk of emerging infections.
Drug resistance occurs when pathologic organisms change in ways that decrease
the ability of a drug (or a family of drugs) to treat disease.
Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant
enterococci (VRE), and penicillin-resistant Streptococcus pneumoniae are three of the
most troublesome drug resistant bacteria currently causing problems in North America.
Pathophysiology
HIV is a ribonucleic acid (RNA) virus, which replicates by using its RNA as a
template to produce deoxyribonucleic acid (DNA), which is then integrated into the
human genome.
Immune dysfunction in HIV infection is caused by damage and destruction of
CD4 T cells (also known as T helper cells or CD4+ T lymphocytes).
+
Diagnostic Studies
The most useful screening tests for HIV are those that detect HIV-specific
antibodies and/or antigens.
The progression of HIV infection is monitored by two important laboratory
assessments: CD4+ T-cell counts and HIV viral load.
Interprofessional Care
Interprofessional management of the HIV-infected patient focuses on (1)
monitoring HIV disease progression and immune function, (2) initiating and monitoring
antiretroviral therapy (ART), (3) preventing the development of opportunistic diseases,
(4) detecting and treating opportunistic diseases, (5) managing symptoms, (6) preventing
or decreasing the complications of treatment, and (7) preventing further transmission of
HIV.
The goals of drug therapy in HIV infection are to decrease the viral load, maintain
or raise CD4+ T-cell counts, prevent the development of HIV-related symptoms and
opportunistic diseases, and delay disease progression.
The major drug classifications for HIV include nucleoside/nucleotide reverse
transcriptase inhibitors (NRTIs), integrase strand transfer inhibitors (INSTIs), protease
inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and
entry/fusion inhibitors.
Treatment regimens can have side effects and frequently interact with
other medications.
Management of HIV is complicated by the many opportunistic diseases that can
develop as the immune system deteriorates.
Examples of opportunistic diseases include Pneumocystis jiroveci pneumonia
(PCP), Mycobacterium avium complex (MAC), and Kaposi sarcoma.